Krishna Jadhav
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Inhalation and Respiratory Drug Delivery 12
-
- Advanced Drug Delivery Systems 8
- Drug Solubulity and Delivery Systems 4
- Advancements in Transdermal Drug Delivery 4
- Co-authors
- Rahul Kumar Verma (24 shared papers)Eupa Ray (10 shared papers)Raghuraj Singh (3 shared papers)Kalpesh Vaghasiya (3 shared papers)Ankur Sharma (3 shared papers)Om Prakash Katare (2 shared papers)Jitendra Naik (8 shared papers)Rehan Khan (1 shared paper)
- Journals
- Drying Technology (3 papers)ACS Infectious Diseases (2 papers)ACS Applied Bio Materials (2 papers)Current Protein and Peptide Science (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- IndiaUnited StatesCanada
In The Last Decade
Krishna Jadhav
24 papers receiving 364 citations
Peers
Comparison fields: 5 of 57
- Pharmaceutical Science 115
- Biomaterials 85
- Pulmonary and Respiratory Medicine 138
- Microbiology 15
- Molecular Medicine 12
Countries citing papers authored by Krishna Jadhav
This map shows the geographic impact of Krishna Jadhav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Jadhav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Jadhav more than expected).
Fields of papers citing papers by Krishna Jadhav
This network shows the impact of papers produced by Krishna Jadhav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Jadhav. The network helps show where Krishna Jadhav may publish in the future.
Co-authors
The 25 scholars most cited alongside Krishna Jadhav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 85 | |
| 2 | 2023 | 44 | |
| 3 | 2023 | 24 | |
| 4 | 2024 | 23 | |
| 5 | 2023 | 22 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 19 | |
| 8 | 2021 | 19 | |
| 9 | 2024 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2024 | 12 | |
| 12 | 2024 | 11 | |
| 13 | 2025 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2025 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 5 |
About Krishna Jadhav
Krishna Jadhav is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Molecular Biology, Epidemiology and Rheumatology, having authored 28 papers that have together received 367 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (12 papers), Advanced Drug Delivery Systems (8 papers), Pneumonia and Respiratory Infections (4 papers), Drug Solubulity and Delivery Systems (4 papers), Advancements in Transdermal Drug Delivery (4 papers), Microencapsulation and Drying Processes (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Pharmaceutical Science (115 citations), Biomaterials (85 citations), Pulmonary and Respiratory Medicine (138 citations), Microbiology (15 citations) and Molecular Medicine (12 citations). Krishna Jadhav has collaborated with scholars based in India, United States and Canada. Frequent co-authors include Rahul Kumar Verma, Eupa Ray, Raghuraj Singh, Kalpesh Vaghasiya, Ankur Sharma, Om Prakash Katare, Jitendra Naik, Rehan Khan, Aniruddha Chatterjee and Raghuraj Singh. Their work appears in journals such as Drying Technology, ACS Infectious Diseases, ACS Applied Bio Materials, Current Protein and Peptide Science and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.